United Therapeutics Chairperson and CEO Martine A. Rothblatt disposes of 9,500 common shares worth $4.69 million

Bitget2026/09/22 20:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

United Therapeutics Chairperson and CEO Martine A. Rothblatt reported transactions in company common stock on Sep. 21, 2026.
A family trust acquired 9,500 shares at USD 117.76 via stock option exercise.
The same trust sold 9,500 shares in multiple trades at weighted-average prices from USD 492.97 to USD 496.62.
Trust holdings ended at 324,443 shares of common stock.
Stock options held by a family trust ended at 394,910 options, exercisable at USD 117.76, expiring Mar. 15, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000146), on September 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics Chairperson and CEO Martine A. Rothblatt disposes of 9,500 common shares worth $4.69 million

You may also like

Crypto prices